Advertisement
Advertisement
TRAW
Traws Pharma, Inc. Common Stock
0.54
USDSponsored
+0.01
+1.50%
Aug 10, 15:59 UTC -4
Closed
After-Market
0.54
0.00
+0.37%
TRAW Earnings Reports
Positive Surprise Ratio
TRAW beat 26 of 36 last estimates.
72%
Next Report
In 2 Days
Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.34
Implied change from Q1 26 (Revenue/ EPS)
--
/-35.85%
Implied change from Q2 25 (Revenue/ EPS)
--
/--
Traws Pharma, Inc. Common Stock earnings per share and revenue
On May 15, 2026, TRAW reported earnings of -0.53 USD per share (EPS) for Q1 26, beating the estimate of -0.75 USD, resulting in a 29.78% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +15.34% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an decrease of -35.85% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ZOETIS INC.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.87
Actual
$1.87
Surprise
-0.22%
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Definium Therapeutics, Inc. Common Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.55
Actual
-$1.44
Surprise
-158.25%
Guardian Pharmacy Services, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.27
Actual
$0.28
Surprise
+3.76%
Cronos Group Inc. Common Share
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.03
Surprise
0.00%
Relmada Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.11
Surprise
+45.95%
Avita Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.25
Surprise
+14.50%
SIGA Technologies Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-Actual
$0.17
Surprise
-
Tonix Pharmaceuticals Holding Corp.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.75
Actual
-$2.44
Surprise
+11.29%
Fractyl Health, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.85%
FAQ
What were Traws Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Traws Pharma, Inc. Common Stock reported EPS of -$0.53, beating estimates by 29.78%, and revenue of $0.00, 0% as expectations.
How did the market react to Traws Pharma, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 15.34%, changed from $1.63 before the earnings release to $1.88 the day after.
When is Traws Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for Traws Pharma, Inc. Common Stock's next earnings report?
Based on 3
analysts, Traws Pharma, Inc. Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement